Skip to main content

Keywords


Precision Medicine Construction Materials Dust Personalized medicine Diagnostic Imaging Multiprotein Complexes Family relationships Arab countries Lasso Germany Chemotherapy Cohort Studies Clinical trials Alkaline Phosphatase Survival Rate ROC Curve Vascular Endothelial Growth Factors Ketoconazole Lymphokines Contraceptives, Oral Confidence Intervals Pregnancy Receptors, Progesterone Population Surveillance Adenocarcinoma, Clear Cell Proportional Hazards Models Alleles Disease Progression Translocation, Genetic African Americans Hispanic Americans DNA Primers Age Factors Molecular Sequence Data DNA, Neoplasm Tamoxifen Ribosomal Protein S6 Kinases Selective Estrogen Receptor Modulators Predictive Value of Tests Cancer Vaccines Retrospective Studies Outcome Assessment (Health Care) Survival Analysis Carcinoma, Renal Cell Prospective Studies Randomized Controlled Trials as Topic Sample Size Clinical Trials, Phase II as Topic United States Risk Assessment Carcinoma Treatment Failure Factor Analysis, Statistical Mining Decision Making Logistic Models Multivariate Analysis Adenocarcinoma Aged, 80 and over Kaplan-Meier Estimate Case-Control Studies Risk Factors Area Under Curve Probability Survival Gene Expression Neoplasms, Hormone-Dependent Endpoint Determination Genotype Ovarian Neoplasms Chemoprevention Graft vs Host Disease Genetic Predisposition to Disease Population DNA Damage Gels Models, Theoretical Sensitivity and Specificity Statistics as Topic Genes, Immunoglobulin DNA Repair Genetics, Medical Validation Studies as Topic Drug Design Mutation Efficiency, Organizational Models, Biological Nomograms Equipment Design Reproducibility of Results Registries Residence Characteristics Prognosis Computer Simulation Models, Statistical Data Interpretation, Statistical HIV Infections Tumor Markers, Biological Research Design Disease-Free Survival Chi-Square Distribution Biomarkers, Pharmacological Decision Support Techniques Urologic Neoplasms Treatment Outcome Odds Ratio Breast Neoplasms Risk Biological Markers